Calidi Biotherapeutics Announces Registered Direct Offering 1,025,640 Shares At $1.17 Per Share

Calidi Biotherapeutics has announced a registered direct offering of 1,025,640 shares at a price of $1.17 per share, with expected gross proceeds of approximately $1.2 million before expenses. The closing of the offering is anticipated on or about September 18, 2026, pending customary closing conditions. The company plans to utilize the net proceeds for working capital and general corporate purposes.